Mylotarg (Gemtuzumab Ozogamicin for Injection) Drug Center: Guide to Drug Information for Professionals, Patients and Caregivers at RxList

Pill Identifier Search

May 27, 2012

Mylotarg

Cancer »

What is cancer?

Cancer is the uncontrolled growth of abnormal cells anywhere in a body. The abnormal cells are termed cancer cells, malignant cells, or tumor cells. Many cancers and the abnormal cells that compose the cancer tissue are further identified by the name of the tissue that the abnormal cells originated from (for example, breast cancer, lung cancer, colon cancer). Cancer is not confined to humans; animals and other living organisms can get cancer. Below is a schematic that shows normal cell division and how when a cell is damaged or altered without repair to its system, the cell usually dies. Also shown is what can occur when such damaged or unrepaired cells do not die and become cancer cells and proliferate with uncontrolled growth; a mass of cancer cells develop. Frequently, cancer cells can break away from this original mass of cells, travel through the blood and lymph systems, and lodge in other organs where they can again repeat the ...

Read the Cancer article »

« Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
Next »

Mylotarg User Reviews >>

Mylotarg

font size

Mylotarg Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Mylotarg Prescribing Information: Indications & Dosage

Mylotarg® (gemtuzumab ozogamicin) Structural Formula Illustration

Mylotarg (gemtuzumab ozogamicin for injection) is indicated for the treatment of patients with CD33 positive acute myeloid leukemia in first relapse who are 60 years of age or older and who are not considered candidates for other cytotoxic chemotherapy. The safety and efficacy of Mylotarg (gemtuzumab ozogamicin for injection) in patients with poor performance status and organ dysfunction has not been established.

The effectiveness of Mylotarg is based on OR rates (see Clinical Studies section). There are no controlled trials demonstrating a clinical ben...

Read the complete drug monograph for Mylotarg »

What is Mylotarg Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Mylotarg Patient Information: Side Effects

Some people receiving a gemtuzumab injection have had a reaction to the infusion (when the medicine is injected into the vein). Tell your caregiver right away if you feel dizzy, nauseated, light-headed, sweaty, or have fever, chills, or trouble breathing within 24 hours after receiving the injection.

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have a serious side effect such as:

pain in your upper right stomach, ...

Read the complete patient information for Mylotarg »

What is Mylotarg Patient Information?

Possible Side Effects - Images - What Is - How Should I Take It - What If I Miss a Dose - What Should I Avoid and More

What is Consumer information?

A concise overview of the drug for the patient or caregiver from First DataBank.

Mylotarg Consumer Information: Uses

This medication is used to treat a certain type of leukemia (acute myeloid leukemia-AML). It is recommended for use in patients whose AML has returned for the first time and who are 60 years or older and cannot use other forms of cancer chemotherapy. This medication works by stopping the growth of cancer cells.

This drug has been withdrawn from the US market due to problems with safety and effectiveness (see also Warning section). For the treatment of AML, the risks outweigh the benefits of gemtuzumab. If you are currently being treated with this medication, talk to your doctor about the ri...

Read the complete consumer information for Mylotarg »